Companies · Healthtech

Soda Health, Inc.

CHICAGO · Healthtech · refined from filed group “Other

Diligence memoA one-page analyst read on Soda Health, Inc. — recommendation, valuation, rhythm, risks.
$84.1M
Total raised · real
3
Rounds
6.0×
Latest step-up
Top 6%
Sector rank · raised
Series C
Latest stage · inferred · Fri Nov 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Soda Health, Inc. looks fair against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.86× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
  • Within the normal band (86% of peer median) for its niche.
Quiet
  • Last raise 20 mo ago; this sector typically re-raises about every 14 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Soda Health, Inc. is one of 2138 Healthtech companies tracked from CHICAGO. By capital raised it ranks among the largest (ahead of 95% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2021
Year incorporated
2024-11-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2022-05-27 Raised $21M (real) Modeled valuation $281M (est)$21M$281MSeries B2022Series B · 2024-04-26 Raised $9.0M (real) Modeled valuation $65M (est)$9.0M$65MSeries B2024Series C · 2024-11-01 Raised $54M (real) Modeled valuation $419M (est)$54M$419MSeries C2024+$9.0M+$54MCumulative $84M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$21.0M · 2022
Series B extension$9.0M · 2024
Series C$54.2M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$419.1M
Base estimate est.
$196.9M
Conservative case
$608.1M
Upside case
$361.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $280.5M · 2022-05-272022Series B · modeled $64.8M · 2024-04-26Series C · modeled $419.1M · 2024-11-012024
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
1.7 yr
Elapsed time used
1.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
15 mo
Avg between rounds
$34.6M/yr
Capital velocity
4.1 yr
On record since
2022
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 19× above median
This company$84.1M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 1.2× above median
This company$54.2M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 12× above median
This company$419.1M
Sector median$33.8M

Raised more than 95% of sector peers (real $). Modeled value above 92% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #24 of 39.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Freedom Dental Funding, LLC · Series C Raised $100.0M · modeled $1.1B (est)Elevate Care International Topco LP · Series C Raised $98.4M · modeled $1.0B (est)Athelas Inc. · Series C Raised $54.4M · modeled $903.4M (est)Hazel Health, Inc. · Series C Raised $86.0M · modeled $817.6M (est)Health Gorilla, Inc. · Series C Raised $58.7M · modeled $816.3M (est)Employee Health Holdings, LP · Series C Raised $78.8M · modeled $779.7M (est)Magnolia Medical Technologies, Inc. · Series C Raised $94.2M · modeled $728.3M (est)Allied Health MSO Holdco, LLC · Series C Raised $62.8M · modeled $724.9M (est)Pearl Health, Inc. · Series C Raised $55.5M · modeled $721.8M (est)Veridian Healthcare Holdings LLC · Series C Raised $63.0M · modeled $692.5M (est)Accompany Health, Inc. · Series C Raised $56.3M · modeled $680.7M (est)Alleviant Medical, Inc. · Series C Raised $148.8M · modeled $677.4M (est)Soda Health, Inc. (this company) Raised $84.1M · modeled $419.1M (est)Soda Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Freedom Dental Funding, LLCSeries C$100.0M$1.1B2.33×
Elevate Care International Topco LPSeries C$98.4M$1.0B2.07×
Athelas Inc.Series C$54.4M$903.4M1.86×
Hazel Health, Inc.Series C$86.0M$817.6M1.68×
Health Gorilla, Inc.Series C$58.7M$816.3M1.68×
Employee Health Holdings, LPSeries C$78.8M$779.7M1.60×
Magnolia Medical Technologies, Inc.Series C$94.2M$728.3M1.50×
Allied Health MSO Holdco, LLCSeries C$62.8M$724.9M1.49×
Pearl Health, Inc.Series C$55.5M$721.8M1.48×
Veridian Healthcare Holdings LLCSeries C$63.0M$692.5M1.42×
Accompany Health, Inc.Series C$56.3M$680.7M1.40×
Alleviant Medical, Inc.Series C$148.8M$677.4M1.39×
Soda Health, Inc. this companySeries C$84.1M$419.1M0.86×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$21.0M2022-05-27$116.4M$280.5M90%
Series B$9.0M2024-04-26$50.0M$64.8M90%
Series C$54.2M2024-11-01$361.2M$419.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$21.0M2022-05-27
    • First recorded raise — entered as Series B.
    • 5 investors on this round.
  2. Series B$9.0M2024-04-26
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 2.3× smaller than the prior — bridge or down round.
    • 9 investors on this round.
  3. Series C$54.2M2024-11-01
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 6.0× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2026 ~Q1
Modeled next raise · ~15mo cadence
$162.5M
Modeled next size est.range $105.6M$260.1M
6.0×
Last step-up
$34.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Lynne Chou O'Keefe6 other2024-04
Caitlin Chou Donovan2024-11
Christopher Elliot Brown2022-05
Galym Elliot Imanbayev2024-04
James Daryl Risinger2022-05
Jared Daryl Dauman2022-05
Mark Chou McDade2024-04
Robert Alan Knight2022-05
Registry & provenance

Soda Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1935407
SEC CIK
2021
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Vori Health Inc.HealthtechSeries C$85.4M$240.5Msame sector · same stage
Apreo Health, Inc.HealthtechSeries C$81.8M$513.3Msame sector · same stage
Adagio Medical, Inc.HealthtechSeries C$81.6M$128.1Msame sector · same stage
Smith Health, Inc.HealthtechSeries C$87.2M$605.5Msame sector · same stage
Genome Medical Holding CoHealthtechSeries C$90.0M$606.2Msame sector · same stage
Folx Health, Inc.HealthtechSeries B$59.3M$355.7Mnetwork1 shared operator · same sector
Form Health, Inc.HealthtechSeries C$76.0M$370.2Msame sector · same stage
Magnolia Medical Technologies, Inc.HealthtechSeries C$94.2M$728.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Pearl Health, Inc.HealthtechSeries C$721.8M85%
CoLabs Medical, Inc.HealthtechSeed$49.4M84%
Health & Technologies IncHealthtechPre-Seed$7.5M83%
HealthAtom Inc.HealthtechSeries A$93.1M83%
Honeybee Health, Inc.HealthtechSeries A$120.9M83%
Watershed Health, Inc.HealthtechSeries A$93.2M83%
Healthe, Inc.HealthtechSeries B$465.2M82%
Keep Healthy, Inc.HealthtechSeries A$225.7M82%
Frequently asked
How much funding has Soda Health, Inc. raised?
Soda Health, Inc. has raised approximately $84.1M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Soda Health, Inc.'s estimated valuation?
Provath's modeled valuation for Soda Health, Inc. is approximately $419.1M (modeled range $196.9M–$608.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Soda Health, Inc. at?
Soda Health, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Nov 01.
What does Soda Health, Inc. do and where is it based?
Soda Health, Inc. operates in the Healthtech sector, based in CHICAGO.
Explore related

See where Soda Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Soda Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.